Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)
Approches Génétiques Intégrées et Nouvelles Thérapies pour les Maladies Rares (INTEGRARE)

France

1 November 2019 - 31 October 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) published between 1 November 2019 - 31 October 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
2 0.95

Outputs by subject (Share)

Subject Count Share
Life Sciences 2 0.95

1 November 2019 - 31 October 2020

International vs. domestic collaboration by Share

  • 50.26% Domestic
  • 49.74% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (5 total)

  • Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE), France
  • Domestic institution
  1. Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering (Oniris), France (0.63)
    0.56
    0.06
  2. Cordelier Research Center (CRC), France (0.52)
    0.39
    0.14
  3. Sorbonne University, France (0.41)
    0.39
    0.03
  4. University of Paris, France (0.41)
    0.39
    0.03
  5. Institute Gustave-Roussy (IGR), France (0.41)
    0.39
    0.03

Top 10 international collaborators by Share (3 total)

  • Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE), France
  • Foreign institution
  1. Spark Therapeutics, Inc., United States of America (USA) (0.86)
    0.39
    0.48
  2. Karolinska Institute (KI), Sweden (0.75)
    0.56
    0.19
  3. The University of Arizona (Arizona), United States of America (USA) (0.75)
    0.56
    0.19

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)

Participating institutions

Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER